Analysis: Alkyl Amines Chemicals Limited

NSE:ALKYLAMINE Speciality Chemicals Market cap: ₹10.1K cr

What does Alkyl Amines Chemicals Limited do?

  • Alkyl Amines Chemicals Limited is a leading manufacturer of amines and related chemicals, headquartered in Navi Mumbai, India.
  • The company operates in the specialty chemicals sector, focusing on methylamines, ethylamines, and acetonitrile for pharma, agrochemical, and industrial applications.
  • The company has manufacturing facilities in Kurkumbh, Dahej, and Patalganga, with a focus on responsible care and sustainability initiatives.
  • Primary products include methylamines, ethylamines, and acetonitrile for pharma, agrochemical, and industrial applications.
  • Recent projects include capacity expansion for Di-Ethyl Ketone (DEK) and debottlenecking of Di-methyl Amine (DMA) production.
  • Exploring new product launches in specialty chemicals, targeting markets like dyes, electronics, and peptides.

Growth thesis

Alkyl Amines produces specialty chemicals (methylamines, ethylamines, acetonitrile) for pharma (50-60% sales), agro (15-20%), and industrial markets. Key growth drivers include the Kurkumbh plant (INR120 cr CAPEX) commissioning in Q1 FY27 for import-substitute products, 30-40% acetonitrile price uplift post-anti-dumping duty, and 1-2 new R&D product launches in 2026-27. Ethylamines capacity sufficiency for 4-5 years and stabilized raw material prices support margin visibility. Over 2-3 years, the Dahej plant and R&D commercialization could drive 5-10% annual volume growth, though methylamines overcapacity from Aarti Drugs may pressure margins. Execution hinges on timely Kurkumbh plant completion and R&D pipeline commercialization.

Why is Alkyl Amines Chemicals Limited stock rising?

  • New product plant at Kurkumbh (for dyes, pigments, electronics) to be commissioned in Q1 FY27 with mechanical completion by end of June 2026; CAPEX of ₹120 crores, import-substitute product with asset turnover ratio of 1.5
  • Expect volume growth of 5-10% in FY27 (normal year) but uncertainty persists due to geopolitical tensions
  • Optimism that margin pressure has bottomed out; expect margin improvement from reduced Chinese dumping and stabilization of raw material prices
  • Chinese anti-involution policy expected to reduce dumping into India, benefiting domestic manufacturers and helping restore margins
  • Methylamines market faces overcapacity with four players (including new entrant Aarti Drugs); no further capacity investment needed for this segment

Research report

companyname: Alkyl Amines Chemicals Limited ticker: ALKYLAMINE sector: Specialty Chemicals Alkyl Amines Chemicals Limited manufactures and sells specialty chemicals, primarily aliphatic amines, their derivatives, and other specialty chemicals. The company was incorporated in 1979. It operates three manufacturing sites—Patalganga (Raigad, Maharashtra), Kurkumbh (Pune, Maharashtra), and Dahej (Bharuch, Gujarat)—plus three solar plants in Maharashtra and Gujarat. As on March 31, 2026, the company ...

Read the full report →

Catalysts

capex, margin expansion

Growth guidance

FY27 volume growth guided at 5-7% in line with country growth driven by market normalization

Guidance no_data

Management consistency

mixed

RS rating: 77 Stage: Stage 2

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Alkyl Amines Chemicals Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.